Purchase Order FA864925P0473
- Not listed
- This is a $74,481 firm-fixed-price purchase order contract awarded by the Air Force Research Laboratory (AFRL) to Epibone, Inc., a small business, to provide a "Solution to Provide Cartilage Replacement for Long-Term and Progressive Usage." The contract is part of the Small Business Innovation Research (SBIR) Program Phase I and is focused on developing innovative bone reconstruction solutions for military personnel suffering from severe bone trauma. Epibone, a for-profit...
- This federal contract award, with an ID of FA864924P0954, is for the "EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY" project, awarded to Epibone, Inc., a small business located in Jersey City, New Jersey. The $74,871 firm fixed-price purchase order was awarded on August 16, 2024 under the Small Business Innovation Research (SBIR) Program Phase I by the Air Force Research Laboratory (AFRL), a defense-oriented federal agency. The contract aims to develop...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Air Force Research Laboratory (AFRL) to Epibone, Inc., a corporate, for-profit organization. The $1,249,628.00 firm-fixed-price contract is focused on validating Epibone's EB-CMF regenerative bone grafts for use in craniofacial surgery, specifically for the maxilla. The research and development work is aimed at providing innovative medical solutions for military personnel suffering from severe bone trauma....
- <p>This federal contract was awarded by the Department of the Army Medical Command to Epibone, Inc., a for-profit organization, for an SBIR (Small Business Innovation Research) Program Phase I project titled "Injectable Off-the-Shelf Cell-Based Therapy Cartilage Filler." The contract has a firm fixed-price of $148,990.22 and a completion date of March 14, 2018. The contract is set aside for small businesses and the place of performance is Brooklyn, NY 11226, USA.</p>
- This is a $3,399,572.70 firm fixed-price contract awarded by the U.S. Air Force Research Laboratory (AFRL) to Embody, Inc., a small business, to produce collagen constructs with extraordinary mechanical strength to accelerate the healing of skeletal muscle injuries. The contract is part of the Department of Defense's Small Business Innovation Research (SBIR) program and is a Phase II action. Embody is a commercial-stage company specializing in collagen-based tendon and ligament healing...
- This is a $74,472 firm fixed-price purchase order awarded by the Air Force Research Laboratory (AFRL) to Matregenix Inc., a minority-owned, self-certified small disadvantaged business manufacturer based in Mission Viejo, California. The contract is part of the Small Business Innovation Research (SBIR) program and is for the development of novel bi-layer biologically-free amino acid nanofiber membranes to enhance dental and craniomaxillofacial surgery outcomes through improved guided bone...
- Embody, Inc. was awarded a $749,603 firm fixed price purchase order from the Department of the Air Force Materiel Command Research Laboratory. The contract is set aside for total small businesses and will fund Embody's research under the Small Business Innovation Research Program Phase II to improve care and operational readiness through developing three-dimensional bioprinted tissue analogs for volumetric muscle loss injuries. As a commercial stage company specializing in collagen-based...
- The U.S. Air Force Research Laboratory (AFRL) awarded a $74,766.00 Small Business Innovation Research (SBIR) Phase I contract to Ora Biomedical, Inc., a minority-owned and small disadvantaged business, to identify therapeutics to improve the health of astronauts in space. The firm-fixed-price purchase order contract has a period of performance through August 19, 2024. This award is part of the AFRL's efforts to support small businesses in developing innovative technologies to address...
- <p>The Department of the Air Force Materiel Command Research Laboratory awarded a $749,510 firm fixed price purchase order to Embody, Inc., doing business as Embody, to support research titled "Improving Care and Operational Readiness with Arthroscopically Delivered Collagen Microfiber-Based Biotextiles" under the Small Business Innovation Research Program Phase II Action. The work will be performed in Norfolk, Virginia through June 11, 2023. No subcontractors were identified.</p>
- This is a $2,235,318.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Embody, Inc., a for-profit organization. The contract is for the development of engineered 3D structures of collagen microfibers for use in surgical soft tissue repair. Embody, a company specializing in collagen-based tendon and ligament healing products, has received multiple prime federal contract awards and grants from the Department of...
The U.S. Air Force Research Laboratory (AFRL) awarded a $1.25M Small Business Innovation Research (SBIR) Program Phase II contract to Epibone, Inc., a Jersey City-based regenerative medicine company specializing in advanced tissue engineering and personalized bone reconstruction. Issued on August 28, 2025, with completion targeted for June 1, 2027, this firm fixed-price purchase order is designated as a total small business set-aside. The contract supports development of EB-OC, a next-generation living osteochondral graft technology designed to treat combat-acquired osteoarthritis in military personnel. This effort represents a continuation of Epibone's collaboration with AFRL on innovative bone and cartilage reconstruction solutions for warfighters experiencing severe musculoskeletal trauma. Epibone's work under this Phase II award builds on the company's established expertise in cultivating patient-specific stem cell technologies and engineered tissue solutions. The SBIR program vehicle, which supports small business innovation in critical defense areas, aligns with AFRL's mission to advance medical technologies for military applications. This contract demonstrates the Department of Defense's commitment to addressing long-term health complications among service members while supporting commercial innovation in regenerative medicine. Epibone's track record includes multiple prior SBIR awards totaling approximately $1.4M focused on craniofacial and cartilage reconstruction, indicating sustained progress in developing viable therapeutic solutions for military medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2m | 8/28/25 |